## Abstract Alpha‐synuclein (α‐syn) is an intracellular protein with a high tendency to aggregation. It is the major component of Lewy bodies and may play a key role in the pathogenesis of Parkinson's disease (PD). α‐Syn is also released by neurons and can be detected in biological fluids, such as
Bromocriptine concentration in saliva and plasma after long-term treatment of patients with Parkinson's disease
✍ Scribed by M. L. Friis; T. Johnsen; N. -E. Larsen; E. F. Hvidberg; H. Pakkenberg
- Publisher
- Springer
- Year
- 1980
- Tongue
- English
- Weight
- 461 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Background: The objective of this study was to examine the clinical outcome and mortality of long-term deep brain stimulation of the subthalamic nucleus in advanced parkinson's disease. ## Methods: We included all 144 patients (mean age, 60.3 years; mean disease duration, 11.0 years) treated i
## Abstract An effect of subthalamic nucleus deep brain stimulation (STN‐DBS) on cognition has been suspected but long‐term observations are lacking. The aim of this study was to evaluate the long‐term cognitive profile and the incidence of dementia in a cohort of Parkinson's disease (PD) patients
## Abstract Acute and chronic behavioral effects of subthalamic stimulation (STN‐DBS) for Parkinson's disease (PD) are reported in the literature. As the technique is relatively new, few systematic studies on the behavioral effects in long‐term treated patients are available. To further study the p